Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0524A vs NIASPAN in Hypercholesterolemia
NCT00533312Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2005
- Primary completion
- Jul 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of laropiprant + niacin in hypercholesterolemia, sponsored by Merck & Co.. Started Apr 2005; status: completed.
02
Drugs
laropiprant + niacin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00533312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00533312.